Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis. | Front Genet | 2023 | 37065479 | PubTator, text mining | PubMed |
| Clinical implications of conflicting variant interpretations in the cancer genetics clinic. | Genet Med | 2023 | 37057674 | PubTator, text mining | PubMed |
| Novel Transcriptomic Interactomes of Noncoding RNAs in the Heart under Altered Thyroid Hormonal States. | Int J Mol Sci | 2023 | 37047531 | PubTator, text mining | PubMed |
| DNA Damage-Mediated Neurotoxicity in Parkinson's Disease. | Int J Mol Sci | 2023 | 37047285 | PubTator, text mining | PubMed |
| High-Risk Pedigree Study Identifies LRBA (rs62346982) as a Likely Predisposition Variant for Prostate Cancer. | Cancers (Basel) | 2023 | 37046747 | PubTator, text mining | PubMed |
| Exploring the Causal Relationship Between Telomere Biology and Alzheimer's Disease. | Mol Neurobiol | 2023 | 37046137 | PubTator, text mining | PubMed |
| Skeletal muscle transcriptomics dissects the pathogenesis of Friedreich's ataxia. | Hum Mol Genet | 2023 | 37027192 | PubTator, text mining | PubMed |
| A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report. | Front Oncol | 2023 | 37025588 | PubTator, text mining | PubMed |
| Targeted next-generation sequencing of 21 candidate genes in hereditary ovarian cancer patients from the Republic of Bashkortostan. | J Ovarian Res | 2023 | 37013556 | PubTator, text mining | PubMed |
| Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis. | Breast Cancer Res Treat | 2023 | 37002487 | PubTator, text mining | PubMed |
| Deep genomic characterization highlights complexities and prognostic markers of pediatric acute myeloid leukemia. | Commun Biol | 2023 | 37002311 | PubTator, text mining | PubMed |
| [Modern Approaches to Protein Engineering to Create Enzymes with New Catalytic Properties]. | Mol Biol (Mosk) | 2023 | 37000650 | PubTator, text mining | PubMed |
| Multimodal treatment with curative intent in a germline BRCA2 mutant metastatic ampullary adenocarcinoma: a case report. | World J Surg Oncol | 2023 | 36998040 | PubTator, text mining | PubMed |
| Germline Variants in MLH1 and ATM Genes in a Young Patient with MSI-H in a Precancerous Colonic Lesion. | Int J Mol Sci | 2023 | 36983044 | PubTator, text mining | PubMed |
| Spectrum of High-Risk Mutations among Breast Cancer Patients Referred for Multigene Panel Testing in a Romanian Population. | Cancers (Basel) | 2023 | 36980780 | PubTator, text mining | PubMed |
| Alternative mRNA Splicing and Promising Therapies in Cancer. | Biomolecules | 2023 | 36979496 | PubTator, text mining | PubMed |
| Evolutionary Origin of MUTYH Germline Pathogenic Variations in Modern Humans. | Biomolecules | 2023 | 36979362 | PubTator, text mining | PubMed |
| Germline Mutations Landscape in a Cohort of the State of Minas Gerais, Brazil, in Patients Who Underwent Genetic Counseling for Gynecological and Breast Cancer. | Rev Bras Ginecol Obstet | 2023 | 36977404 | PubTator, text mining | PubMed |
| Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy. | NPJ Precis Oncol | 2023 | 36973365 | PubTator, text mining | PubMed |
| UV-DDB stimulates the activity of SMUG1 during base excision repair of 5-hydroxymethyl-2'-deoxyuridine moieties. | Nucleic Acids Res | 2023 | 36971122 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=26